Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ASPERMONT LIMITED. Director's Dealing 2020

Feb 4, 2020

64436_rns_2020-02-04_1716b464-5bf4-4134-ba39-b378a4767cb5.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Aspermont Limited

ABN 66 000 375 048

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Alexander L. Kent
Date of last notice 24 May 2019

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct and Indirect
Nature of $0.0078indirect interest(including registered holder)Note: Provide details of the circumstancesgiving rise to the relevant interest. Mega Hills Limited - Beneficial
Date of change 5 February 2020
No. of securities held prior tochange 1. 259,749,245 ordinary shares;2. 258,245,641 Unlisted Options $0.03 / 30 Sep 20253. 48,000,000 Performance Rights ASPPER01
Class 1. Ordinary Shares2. Unlisted Options $0.03 strike, expiry 30 September20253. Unlisted Incentive Performance Rights ASPPER01
Number acquired 21,000,000 Performance Rights ASPPER01
Number disposed nil
Value/ConsiderationNote: If consideration is non-cash, providedetails and estimated valuation Nil considerationEstimated issue price is $0.0078 per right
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

ary shares;ted Options $0.03 / 30 Sep 2025rmance RightssissuedinaccordancewithPlan as approved by shareholderseneral Meeting 3 February 2020.
No. of secu rities held after change 1. 259,749,245 ordin2. 258,245,641 Unlis3. 69,000,000 Perfo ary shares;ted Options $0.03 / 30 Sep 2025rmance Rights
Nature ofExample: on-exercise of opdividend reinvbuy-back changemarket trade, off-market trade,tions, issue of securities underestment plan, participation in PerformanceRightPerformance RightsAspermont Annual G sissuedinaccordancewithPlan as approved by shareholderseneral Meeting 3 February 2020.
Part 2 – C ane of director’s interests in contracts

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A N/A
Nature of interest N/A
Name of registered holder N/A
(if issued securities)
Date of change N/A
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed N/A
Interest acquired N/A
Interest disposed N/A
Value/ConsiderationNote: If consideration is non-cash, provide detailsand an estimated valuation N/A
Itt ft h N/A
neres aer cange

Part 3 –[+] Closed period

+ + + + +
Part 3 –Closed periodWere the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?No
Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required? No
If so, was prior written clearance provided to allow the tradeto proceed during this period? N/A
If prior written clearance was provided, on what date was this N/A
provided?
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011